Deletion of the V1/V2 region does not increase the accessibility of the V3 region of recombinant gp125

Curr HIV Res. 2006 Apr;4(2):229-37. doi: 10.2174/157016206776055066.

Abstract

Previous analyses of HIV-1 surface glycoprotein indicate that both the V1/V2 region and the interaction of gp120 with CD4 influence the accessibility of the V3 region on gp120. In this study we investigated the accessibility of the V3 region of HIV-2 recombinant gp125 proteins using V3-specific mAbs (7C8 and 3C4) and analyzed the binding kinetics of soluble CD4 (sCD4) to recombinant HIV-1 gp120 and HIV-2 gp125 proteins by surface plasmon resonance (SPR) analysis. Our results indicated that 7C8 recognized monomers of gp125 and gp125Delta v1v2, (lacking the V1/V2 region) while 3C4 was sensitive to the conformation of gp125, recognizing only oligomers of gp125Delta v1v2. Furthermore, SPR analysis of 7C8 binding to gp125 demonstrated that the deletion of the V1/V2 region did not increase the accessibility of the V3 region in gp125Delta v1v2. Comparative SPR analyses of sCD4 binding HIV recombinant surface glycoproteins revealed a lower affinity of sCD4 to gp125 as compared to gp120. Moreover, the analyses suggest that conformational changes only occur in HIV-1 gp120 upon interaction with CD4. We hypothesize that the V3 region is accessible in HIV-2 gp125 and thus may not require interaction with CD4 to induce conformational reorientation of the V1/V2 region.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal / immunology
  • Blotting, Western
  • CD4 Antigens / immunology
  • Enzyme-Linked Immunosorbent Assay
  • Gene Products, env / immunology*
  • Gene Products, env / metabolism
  • HIV Envelope Protein gp120 / immunology*
  • HIV Envelope Protein gp120 / metabolism
  • HIV-1 / immunology
  • HIV-2 / immunology*
  • HIV-2 / metabolism
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • Peptide Fragments / immunology*
  • Peptide Fragments / metabolism
  • Protein Conformation
  • Protein Precursors / immunology*
  • Protein Precursors / metabolism
  • Recombinant Proteins / immunology
  • Sequence Alignment
  • Surface Plasmon Resonance
  • env Gene Products, Human Immunodeficiency Virus

Substances

  • Antibodies, Monoclonal
  • CD4 Antigens
  • Gene Products, env
  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Peptide Fragments
  • Protein Precursors
  • Recombinant Proteins
  • env Gene Products, Human Immunodeficiency Virus
  • gp125 envelope protein, Human immunodeficiency virus 2